Britain has agreed to use the Pfizer vaccine extensively, and within the next week, priority will be given to groups that will receive treatment.
According to Arabnet, Pfizer and Biontec have submitted an application to the European Union to obtain a license for the Corona vaccine.
and in the middle of last month, Pfizer and Biontech announced that the efficacy portion of the Covid-19 vaccine trial had been completed, indicating that the vaccine is 95% effective.
the companies said at the time that they plan to apply to the Food and Drug Administration for permission to use in emergency situations within days, and will also submit to regulatory agencies around the world.
The results come just over a week after the two companies announced that an earlier analysis of the study showed that the vaccine reduced infections by more than 90%, and only days after Moderna's announcement , That a similar vaccine reduced infection by 94.5%.
> Taken together, the results raise hopes that vaccines will be widely available sometime next year, and perhaps also, that other vaccines that combat the disease will also prove effective.
